MONTREAL — Lawyers involved in a class-action lawsuit over the drug Rexulti say a $4.75 million settlement has been reached on behalf of patients and the estates and families of those who were prescribed the drug.
Settlement reached in national class-action lawsuit over drug Rexulti: law firm
